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Abstract 
A large screening of around 1000 emerging contaminants, focused on licit and illicit 
drugs and their metabolites, has been made in urban wastewaters (both influent and 
effluent) and surface waters from the area of Bogotá, Colombia. After a simple generic 
solid-phase extraction (SPE) step with Oasis HLB cartridges, analyses were made by 
ultra high-performance liquid chromatography coupled to quadrupole time-of-flight 
mass spectrometry (UHPLC-QTOF MS) under MS
E
 mode (sequential acquisition of 
mass spectra at low energy (LE) and high collision energy (HE)). Accurate-mass 
measurements and the information provided by MS
E
 on the presence of the 
(de)protonated molecule and fragment ions allowed the reliable identification of the 
compounds detected, even without reference standards being available in some cases 
(tentative identification). The compounds most frequently found were 
acetaminophen/paracetamol, carbamazepine and its dihydro-dihydroxylated metabolite, 
clarithromycin, diclofenac, ibuprofen, gemfibrozil, lincomycin, losartan, valsartan, the 
two metabolites of metamizole (4-acetamido-antipyrine and 4-formylamino-antipyrine), 
sucralose, and cocaine and its main metabolite benzoylecgonine. Caffeine, the 
sweetener saccharin and two hydroxylated metabolites of losartan were tentatively 
identified in almost all samples analysed. Pharmaceutical lidocaine was tentatively 
identified and subsequently confirmed with reference standard. For the first time, a 
general overview of the occurrence of drugs and their metabolites in the aquatic 
environment of Colombia has been reported. In the near future, target methodologies, 
typically based on LC-MS/MS, will need to be set up for accurate and sensitive 
quantification of the contaminants selected on the basis on the information provided in 
the present paper. 
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Introduction 
Changes in industry, agriculture and urban development present interlinked challenges 
to water quality [1, 2]. Due to the increasing use of pharmaceuticals and personal-care 
products (PCPs) as well as veterinary drugs and illicit drugs, the amount of these newly 
emerging chemicals detected in waters raise environmental and health concerns. Many 
of these contaminants survive the passage through conventional wastewater treatment 
processes resulting in the growing discharge of these compounds into receiving waters 
where their presence is increasingly common [3, 4]. However, little information is 
available from Latin America despite the fact that this region undergoes rapid land, 
economical, and social changes [5] and where, in some areas, the discharge of raw 
sewage into rivers, lakes and reservoirs are widely practiced [6 - 8]. Concern over the 
presence of these contaminants is well founded as these rivers not only flow through 
tropical areas rich in biodiversity, but surface waters are also used as a source for human 
consumption after conventional chlorination processes or directly as irrigation water 
without any treatment.   
Monitoring licit and illicit drugs is generally based on multi-residue methodologies 
using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) for 
target substances considered as harmful for human health or the ecosystem. Analyses 
are commonly focused on a limited number of priority compounds, and the main 
objective is the accurate quantification of the target analytes. However, the use of 
pharmaceuticals and veterinary drugs differs temporally and spatially between regions 
and countries due to different marketing, regulations, prescription practices, etc. [9]. 
Thus, drugs used in Latin America may differ from those generally prescribed or 
consumed in Europe and North America. Accordingly, target approaches applied for 
routine analysis of water samples in one country might ignore important contaminants 
from another country, as they are simply not included in the scope of the method. 
Therefore, a large screening of contaminants is of high interest in order to define 
priority compounds and to subsequently set up target methodologies for monitoring. To 
this end, High Resolution Mass Spectrometry (HRMS) plays an important role for 
screening of emerging contaminants, in relevant fields like environmental pollution [10, 
11].  
Hybrid HRMS, such as a quadrupole time-of-flight mass spectrometry (QTOF MS) in 
MS
E
 or all ions MS/MS mode (the term depends on the manufacturer), has 
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demonstrated its use as an advanced tool that allows the investigation of hundreds of 
compounds in the same run, making use of home-made databases [12 - 14]. The 
presence of compounds in samples can be investigated once the analysis has been 
performed and data acquired, without being dependent on the pre-selection of analytes. 
It allows detection/rapid screening for compounds by means of searching the exact mass 
of the (de)protonated molecules in the full spectra generated using low collision energy 
(LE function). Confirmation with reference standards, or tentative identification, could 
subsequently be performed searching for exact masses of fragment ions in the acquired 
spectra at high collision energy (HE), where fragmentation of the molecule is promoted.  
We performed a previous monitoring in the irrigate district of Usosaldaña, an important 
agricultural area in Colombia, mainly devoted to the cultivation of rice. Analysis of 
surface water and soil samples by TOF MS, coupled to both gas and liquid 
chromatography, revealed the presence of several pesticides and metabolites in most of 
the samples. Also, some personal care products were identified [15]. However, there is 
little or no information on the presence of emerging organic contaminants in the area of 
Bogotá. In the present work, a large screening of pharmaceuticals belonging to different 
therapeutic groups, veterinary drugs, X-ray agents, PCPs (preservatives and UV filters), 
sweeteners, illicit drugs and a notable number of metabolites has been performed in urban 
wastewaters (both influent and effluent) and receiving surface waters from the 
surrounding area of Bogotá. A customized database with more than 1000 emerging 
contaminants was developed including pharmaceuticals frequently prescribed in 
Colombia. As far as we know, this is the first wide-scope screening based on HRMS that 
has been applied to this aim. Henceforth, future monitoring in this area can be focused on 
the compounds identified in this initial step.  
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Material and Methods  
Chemicals and standards 
865 human and veterinary pharmaceuticals including metabolites (see Supplementary 
information (SI), Table SI1), 29 X-Ray agents (Table SI2), 20 UV-filters (Table SI3), 
4 preservatives (Table SI4), 9 sweeteners (Table SI5) and 130 illicit drugs including 
metabolites (Table SI6) were studied, of which 215 reference standards were available 
(* in Tables SI1 – SI6).  
Reference standards of these compounds were purchased from Across Organics (Geel, 
Belgium), Aventis Pharma (Madrid, Spain), Bayer Hispania (Barcelona, Spain), 
Cerilliant (Round Rock, TX, USA), Fluka (Buchs, Switzerland), Dr. Ehrenstorfer 
(Augsburg, Germany), Fort Dodge Veterinaria (Gerona, Spain), LGC Promochem 
(London, UK), National Measurement Institute (Pymble, Australia), Riedel-de Haën 
(Seelze, Germany), Sigma Aldrich (St Louis, MO, USA), Toronto Research Chemicals 
(Ontario, Canada), Vetoquinol Industrial (Madrid, Spain), and Witega (Berlin, 
Germany). All reference materials had purities higher than 98% (w/w), except for 
marbofloxacin and pefloxacin, which had purities higher than 93%.  
HPLC-grade methanol (MeOH), HPLC-grade acetonitrile (ACN), sodium hydroxide 
(NaOH) (>99% w/w) and formic acid (HCOOH) (>98 % w/w) were purchased from 
Scharlau (Barcelona, Spain). Leucine enkephalin was purchased from Sigma Aldrich 
(Madrid, Spain). HPLC-grade water was obtained by purifying demineralised water in a 
Milli-Q plus system from Millipore (Bedford, MA, USA). Solid-phase extraction (SPE) 
cartridges used were Oasis HLB 3 cm
3
 (60 mg) from Waters (Milford, MA, USA). 
 
Samples 
Seven influent wastewater (IWW) samples and seven effluent wastewater (EWW) 
samples were taken from the Salitre wastewater treatment plant (WWTP), in Northwest 
Bogotá D.C., Colombia, which serves a population of approximately three million 
inhabitants. The 24-hour composite samples were collected over seven consecutive days 
in March 2014 (starting on Wednesday March 12
th
 and ending on Tuesday March 18
th
) 
in high density polystyrene bottles, immediately centrifuged and stored in the dark at -
20°C until analysis. In addition, ten grab surface water (SW) samples were collected 
from around Bogota (Figure 1) in July 2013, concerning areas of interest along the 
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Tunjuelo River (samples 1-4) and in La Ramada Irrigation District (samples 5-10). 
Seven individual samples (250 mL) were taken for each sampling point. These were 
then combined to form a composite sample to provide a more complete overview of 
each area. An aliquot was then taken for the sample treatment and subsequent analysis. 
 
Sample Treatment  
An SPE step was applied prior to analysis to pre-concentrate the sample. All samples 
were filtered through 0.45 μm mixed cellulose ester membrane filter (Whatman, Dassel, 
Germany). SPE was performed using Oasis HLB cartridges (60 mg). The cartridges 
were conditioned by washing and rinsing with 6 mL MeOH and 6 mL Milli-Q water. 
The water samples (IWW was four times diluted with MilliQ water, i.e. 25 mL sample 
in 100 mL; EWW and SW was 100 mL, no dilution) were loaded onto the cartridges, 
percolated by gravity (flow rate around 3 mL/min) and vacuum dried for approximately 
15 min. Analytes were eluted with 5 mL MeOH. The extracts were evaporated to 
dryness at 35°C under a gentle stream of nitrogen and reconstructed in 1 mL of 10:90 
MeOH:H2O. Analyses were performed by injecting 20 μL of the final extract into the 
UHPLC-QTOF-MS 
 
Instrumentation 
A Waters Acquity UPLC system (Waters, Milford, MA, USA) was interfaced to a 
hybrid quadrupole-orthogonal acceleration-TOF mass spectrometer (XEVO G2 QTOF, 
Waters Micromass, Manchester, UK), using a Z-Spray ESI interface operating in both 
positive and negative ion mode. The chromatographic separation was performed using 
an Acquity UPLC BEH C18 1.7 µm particle size column 100 × 2.1 mm (Waters) at a 
flow rate of 300 µL/min. The mobile phases used were A = H2O with 0.01% HCOOH 
and B = MeOH with 0.01% HCOOH. The initial percentage of B was 10%, which was 
linearly increased to 90% in 14 min, followed by a 2 min isocratic period and, then, 
returned to initial conditions during 2 min. The total run time was 18 minutes. Nitrogen 
was used as drying gas and nebulizing gas. The desolvation gas flow was set at 1000 
L/h and the cone gas at 80 L/h. TOF-MS resolution was approximately 20,000 at full 
width half maximum (FWHM) at m/z 556. 
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MS data were acquired in centroid mode over an m/z range of 50–1000 Da. Data were 
acquired in both positive and negative ionization modes in two separate runs. A 
capillary voltage of 0.7 kV and 2.5 kV were used in positive and negative ionizations 
modes, respectively. A cone voltage of 20 V was used. Collision gas was argon 
99.995% (Praxair, Valencia, Spain). The desolvation temperature was set to 600°C, and 
the source temperature to 130 °C. The column temperature was set to 40°C. 
For MS
E
 experiments, two acquisition functions with different collision energies were 
created. The low energy (LE) function, selecting a collision energy of 4 eV, and the 
high energy (HE) function, with a collision energy ramp ranging from  15-40 eV in 
order to obtain a greater range of fragment ions. The LE and HE functions settings were 
for both a scan time of 0.4 s. 
For elucidation of losartan metabolites, MS/MS experiments at different collision 
energies (10, 20, 30, 40 and 50 eV) were performed to promote higher fragmentation 
and also to ensure that fragment ions observed in MS
E 
come from the parent ion. 
 
Data Processing 
Processing of MS data was done using ChromaLynx XS application manager (within 
MassLynx v 4.1; Waters Corporation). The following parameters were used for 
screening: mass window 150 ppm (for positive ID ≤ 5 ppm), isotope fit as well as 
retention time (maximum deviation of ≤ 2.5%) and fragmentation, when available. 
Software specific settings were: peak width at 5% height: 6 seconds, peak-to-peak 
baseline noise: 1000 and threshold absolute area: 200.  
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Results and discussion 
Detection, confirmation and tentative identification 
The full-spectrum accurate-mass data, generated by QTOF under MS
E
 mode, were 
inspected in ChromaLynx XS (within MassLynx) using a home-made database 
containing 1057 LC-amenable organic contaminants (Tables SI1 – SI6), which is 
continuously being updated. Analytes were mostly selected based on our own 
experience and on existing compound lists encountered in the literature on LC–MS 
methods for determination of organic contaminants. Empirical data (retention time, 
adduct information and/or fragment ions) obtained from compounds of which reference 
standards (up to 215) were available in our laboratory was included. This information 
was used for an easier and more straightforward detection and unambiguous 
confirmation of the identity of the compound. Furthermore, pharmaceuticals frequently 
prescribed in Colombia were also included. For those compounds for which reference 
standards were not available at our laboratory, the only information  included in the 
database was the name and elemental composition of the compounds. Here, the tentative 
identification was a manual and more time-consuming process, incorporating internet 
resources, such as MassBank [16] or MetLin [17]  to look for information about 
possible fragment ions.  
The confidence in HRMS based identification is an important issue as pointed out by 
Schymanski et al. [18]. Discussion on how to best communicate confidence regarding 
identification for the exchange of results via literature and databases is on-going, but 
criteria are needed and should be well reported. Criteria used in this study were based 
on the availability (detection and confirmation of the identity) or non-availability 
(tentative identification) of reference standards. The information given by QTOF MS 
spectra, both LE and HE accurate mass spectra, and retention times allowed the 
compounds to be distinguished using different possibilities: 
 
 Detection, based on the presence of 1 accurate-mass ion (mass error ≤ 5 ppm) 
and retention time agreement (maximum deviation ≤ 2.5%) 
 Confirmation of the identity, with at least 2 accurate-mass ions (≤ 5 ppm) and 
retention time (≤ 2.5%) 
 Tentative identification, with at least 2 accurate-mass ions justified by literature 
data and /or compatibility with candidate chemical structure 
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For those compounds containing chlorine or bromine atoms, the characteristic isotopic 
profile should be observed. However, we considered the isotopic pattern as a pre-
requisite for identification, but not as valuable as an accurate-mass fragment ion. 
Therefore, when only those ions corresponding to the parent compound and the isotopic 
peak were present, we considered the compound as detected, not as confirmed. 
 
In the case of tentative identification, reference standards and additional MS/MS 
experiments would be necessary for final unequivocal confirmation of the compounds. 
However, we do not need expensive reference standards for all 1057 compounds in the 
database, only for the positive findings. From our previous experience, the subsequent 
acquisition of reference standards has allowed confirmation of nearly all tentative 
identifications. This supports the high degree of reliability of tentative identification by 
using this technique [19]. 
 
Screening of Colombian water samples 
In order to perform a large screening, a non-selective sample treatment and a generic 
chromatographic separation was chosen to broaden the system applicability to as many 
compounds as possible. Due to the large level of dilution in these types of samples, SPE 
was performed, using a generic Oasis HLB cartridge for pre-concentration and to enable 
detecting the analytes at the low concentration levels normally present. Using this 
analytical procedure and from the information obtained by UHPLC-QTOF MS under 
MS
E
 mode, several compounds could be detected, confirmed and/or tentatively 
identified in all type of Colombian water samples analyzed (Table 1).  
Samples were screened for pharmaceuticals belonging to different therapeutic groups, 
veterinary drugs, X-ray agents, PCPs (preservatives and UV filters), sweeteners, illicit 
drugs and several metabolites. The compounds most frequently detected were the 
analgesics/anti-inflammatories N-acetyl-p-aminophenol (commonly known as 
acetaminophen or paracetamol), diclofenac, ibuprofen and lidocaine. The antibiotics 
clarithromycin and lincomycin, the angiotensin II antagonists valsartan and losartan, the 
anti-epileptic carbamazepine, the beta-blocker metoprolol, the lipid regulator 
gemfibrozil and the X-ray agent iopromide were also found. It is interesting to remark 
the detection or tentative identification of several metabolites such as those of 
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metamizole (4-acetylamino-antipyrine and 4-formylamino-antipyrine), carbamazepine-
10,11-dihydro-10, 11-dihydroxy and three metabolites of losartan (losartan carboxylic 
acid, and two hydroxy-losartan isomers). Furthermore, the sweeteners acesulfame, 
sucralose and saccharin and the psychoactive drugs, cocaine and its main metabolite 
benzoylecgonine, as well as caffeine were frequently detected or tentatively identified. 
UV-filters were not detected, while the preservatives methylparaben and propylparaben 
were found, but only in wastewater samples. 
These data are consistent with studies on over the counter medicines in Colombia, 
where analgesics are most frequently sold (60%), in Bogotá [20]. In addition, 11% of 
the population of Bogotá has been diagnosed with hypertension of which 5.5% taking 
mainly losartan, valsartan and metoprolol for its control [21] and regarding antibiotics, 
clarithromycin and lincomycin are most often prescribed [22].   
Based on general population surveys, cocaine is the second most consumed illicit drug, 
but the main illicit psychoactive drug consumed in Colombia is cannabis [23]. 
However, the main metabolite of cannabis (11-nor-9-carboxy-Δ9-tetrahydrocannabinol 
(THC-COOH)), which is commonly used as biomarker in wastewater for cannabis 
consumption, was not detected. This was probably due to the low sensitivity of the 
technique applied for this compound. The analytical problems found in the 
determination of this compound have been widely recognized in the literature [24 - 26].     
Most compounds were found in both wastewaters (influent and effluent) and surface 
waters suggesting incomplete removal by WWTPs and possible disposal to receiving 
surface waters. The pharmaceuticals carbamazepine and its metabolite carbamazepine-
10, 11-dihydro-10, 11 dihydroxy, acetaminophen, diclofenac, ibuprofen, the highly 
consumed caffeine, cocaine and its metabolite benzoylecgonine are widely occurring 
contaminants in the aquatic environment, having been reported to be also present in 
Brazilian surface waters [5, 7]. 
In relation to surface waters, the presence of pharmaceuticals was more noticeable in 
samples collected from the Tunjuelo river (samples 1 to 4) -a tributary of the Bogotá 
river- in the south of Bogotá. In this area, around 2.5 million inhabitants discharge their 
sewage directly to this river without any treatment. In addition, solid urban waste are 
located here (Doña Juana landfill, Figure 1) and potential leaching surely contributes to 
the pollution in the area.  This can explain that the profile of emerging contaminants 
found in these surface waters and in wastewaters collected from Salitre WWTP was 
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rather similar, in both cases reflecting the drug consumption of a large population (2.5 - 
3 million inhabitants). 
In contrast, the irrigation area of Ramada -supplied by the Bogotá river in its northern 
part- may be affected by industrial and urban waste, albeit with a lower population 
(around 600.000 inhabitants). Although these surface water samples (5 to 10) had 
several contaminants in common with those samples from the Tunjuelo river and with 
wastewater samples, the number of compounds detected was notably lower. Despite this 
fact, the presence of emerging contaminants may have undesirable consequences for 
public health as these waters are mainly used for irrigation on this agricultural area. A 
more in-depth study would be required to quantify the compounds detected in water 
samples from this area for better knowledge and estimation of potential human risks.  
Below, some examples are given in detail, to illustrate the screening strategy applied in 
this study, which led to the detection, confirmation or tentative identification of several 
compounds. The different possibilities considered in this work will be taken into 
account: presence/absence of reference standards in the laboratory, and searching for 
known and unknown metabolites on the basis of common fragmentation pathway 
between parent compound and possible metabolites. 
 
a)  Reference standards available 
Up to 215 reference standards were available in our laboratory and, therefore, 
experimental data such as retention time and fragment ions could be included in the 
home-made database. This information was used for easier detection and unambiguous 
confirmation of the identity of the compounds. Figure 2 shows the unequivocal 
confirmation in surface water of 4-acetamido antipyrine, a metabolite of the widely used 
analgesic metamizole. The LE spectrum (Figure 2a, top) of the peak at 3.78 min showed 
the m/z corresponding to the protonated molecule (m/z 246.1237) with a mass error of -
2.4 ppm. The HE spectrum (Figure 2a, bottom) also showed the remaining protonated 
molecule and five fragment ions with mass errors all below 5 ppm. In this figure, 
narrow-window eXtracted Ion Chromatograms (nw-XICs) for the six m/z ions are also 
depicted, with a chromatographic peak at exactly the same retention time. 
In a similar way, most of the detected compounds could be confirmed in the samples 
(see the compounds marked as inTable 1). The compounds metoprolol and codeine 
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could not be confirmed despite the reference standards were available, as only the 
protonated molecule was observed at the corresponding retention time. In these cases 
the compounds were marked as detected ( in Table 1). Additional analysis would be 
required to promote the fragmentation, using higher collision energies in new MS/MS 
experiments. 
 
b) Reference standards not available 
When reference standards were unavailable, the only information included in the 
database was the name and elemental composition of the contaminants. Even in this 
situation, a tentative identification could be performed on the basis of the relevant 
information on the accurate mass of the (de)protonated molecule and the fragment ions 
offered by QTOF MS
E
. Figure 3 illustrates the potential of this screening approach with 
two case studies: the detection and tentative identification of lidocaine and caffeine in 
effluent wastewater.  
The LE spectrum in ESI positive of an abundant chromatographic peak at 3.97 min, 
showed an intense signal at m/z 235.1808 (Figure 3a, bottom). This might correspond 
to the protonated molecule of lidocaine (C14H23N2O, expressed as protonated molecule), 
with a mass error of -0.9 ppm in relation with the theoretical exact mass. The LE 
spectrum also showed an important signal at m/z 195.0883 (retention time 3.89 min) 
which could be attributed to caffeine (C8H11N4O2, 0.5 ppm mass error). The HE 
spectrum showed 3 fragment ions at m/z 138.0667 (C6H8N3O), 110.0716 (C5H8N3) and 
86.0971 (C5H12N), all with mass errors below 2 ppm (Figure 3a, top). At this point, 
UHPLC was a valuable tool for selecting almost co-eluting fragment ions that might 
correspond to different precursor ions. Thus, the fragments at m/z 138 and 110 were 
related to caffeine, whereas the fragment at m/z 86 was related to lidocaine. The 
structure of the fragment ions were justified on the basis of their measured accurate 
masses, which was moreover in agreement with the information available in scientific 
literature [16, 17]. Lidocaine could be tentatively identified and subsequently confirmed 
after acquiring its reference standard ( in Table 1). The confirmation of caffeine 
would require the injection of the reference standard, which at the time of writing this 
paper was not available at our laboratory (we did not consider this compound relevant 
in our study). Similar situations occurred for other compounds tentatively identified, as 
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metformin, pirantel and the sweetener saccharin, due to the lack of reference standard 
( in Table 1). 
 
c) Searching for metabolites 
A detailed discussion is made on the particular case of losartan, an angiotensin II 
receptor antagonist drug used mainly to treat high blood pressure (hypertension), and its 
metabolites identified making use of the common fragmentation pathway.  
Losartan was confirmed to be present in all the samples analyzed. The LE spectrum in 
ESI+ showed an abundant chromatographic peak at the expected retention time (10.13 
min) for this pharmaceutical (m/z 423.1695, -1.2 ppm mass error) and also presented the 
typical isotopic pattern of a chlorine atom (C22H24N6OCl, expressed as protonated 
molecule). The expected fragment ion at m/z 405.1590 (C22H22N6Cl, -1.0 ppm), due to a 
loss of water, was also observed in the LE spectrum, as well as a minor fragment ion at 
m/z 377.1528 (C22H22N4Cl, -1.3 ppm), corresponding to a N2 loss from m/z 405. The HE 
spectrum showed a predominant ion at m/z 207.0916 (C14H11N2), and minor peaks at 
m/z 235.0979 (C14H11N4), 192.0813 (C14H10N), 190.0661 (C14H8N) and 180.0805 
(C13H10N), all with mass errors below 4 ppm. These fragments correspond to the 
fragmentation at the benzylic carbon (CH2 near to the two rings) (m/z 235) with losses 
of N2 (m/z 207), N3H (m/z 192) or N3H3 (m/z 190). Losartan was also detected in 
negative mode at m/z 421.1552, showing fragment ions at m/z 187.0631 (C8H12N2OCl), 
179.0868 (C14H11), 157.0529 (C7H10N2Cl) and 127.0066 (C5H4N2Cl). With all this 
information, the compound detected in the samples was unequivocally confirmed to be 
losartan. 
The presence of three additional chromatographic peaks at 8.25, 9.29 and 10.47 min in 
all the three XICs at m/z 207, 235 and 190 performed at the HE function in ESI+ (for 
losartan, retention time 10.13 min) suggested that the three compounds were chemically 
related with this pharmaceutical (Figure 4). The common fragmentation pathway 
strategy has been successfully applied by our group in the elucidation of metabolites of 
the new psychoactive substance methylenedioxypyrovalerone (MDPV) and of 
degradation products of cocaine and benzoylecgonine [27, 28]. This encouraged us to 
investigate the identity of the potential metabolites/transformation products of losartan 
from the data provided by QTOF MS.  
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Firstly, the LE spectra (all showing the isotopic distribution corresponding to a chlorine 
atom) of these 3 possible metabolites were studied in more detail. In relation to the peak 
at 10.47 min, the protonated molecule corresponded to m/z 437.1490 (C22H22N6O2Cl, -
0.7 ppm), which might be attributed to an oxidation of losartan. This compound might 
correspond to losartan carboxylic acid, the main metabolite reported in the literature 
[29]. 
Regarding the peaks at 8.25 and 9.29 min, accurate masses of m/z 439.1643 and 
439.1661 were obtained, respectively, both corresponding to the same empirical 
formulae C22H24N6O2Cl with mass errors lower than 3 ppm. This implies the presence 
of an extra oxygen atom with respect to losartan. Hence, these two compounds might 
correspond to hydroxylated metabolites of losartan.  
The following step consisted on the elucidation of the structure of these three potential 
metabolites. For this purpose, MS/MS experiments were performed at different collision 
energies (10-50 eV).  
Regarding the peak at 10.47 min (m/z 437.1490, C22H22N6O2Cl, -0.7 ppm), 5 common 
product ions with losartan were observed at m/z 235.0982, 207.0919, 192.0816, 
190.0654 and 180.0809. This compound was also detected in negative mode, with m/z 
435.1327 (C22H22N6O2Cl, -2.1 ppm). At the lowest collision energy, a product ion was 
observed at m/z 391.1429 (C21H20N6Cl, -2.3 ppm), corresponding to a loss of CO2. 
When the collision energy was increased, product ions at m/z 363.1375 (C21H20N4Cl, 
this is a N2 loss from 391, -0.3 ppm), 157.0530 (C7H10N2Cl, -1.9 ppm) and 113.9989 
(C4H3N2Cl, 3.5 ppm) were observed. All these fragments fitted with the chemical 
structure of losartan carboxylic acid. After this careful evaluation and well-supported 
tentative identification, the reference standard of losartan carboxylic acid was acquired 
and injected, allowing the ultimate confirmation of this metabolite in the samples.  
Regarding the hydroxylated metabolite 1 (8.25 min, m/z 439.1643, C22H24N6O2Cl, -1.4 
ppm), two minor product ions were observed at 10 eV at m/z 421.1536 (C22H22N6OCl) 
and 385.1772 (C22H21N6O), resulting from a loss of water and subsequent loss of 
hydrochloric acid. At higher collision energies, product ions at m/z 235.0978 
(C14H11N4), 207.0915 (C14H11N2), 192.0806 (C14H10N), 190.0649 (C14H8N) and 
180.0803 (C13H10N) were obtained (Figure 5a). Thus, ESI+ fragmentation advise about 
what is happening near to the tetrazol group but not about the location of the hydroxyl 
group. Accordingly, these fragments seem to indicate that the hydroxylation has 
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occurred in the imidazole part. In negative mode, product ions at m/z 203.0585 
(C8H12N2O2Cl) and 173.0488 (C7H10N2OCl) were observed at 20 eV. When the 
collision energy was increased up to 50 eV, product ions at m/z 155.0384 (C7H8N2Cl), 
127.0060 (C5H4N2Cl), 113.9991 (C4H3N2Cl) and 100.9912 (C3H2N2Cl) were observed 
(Figure 5b). Considering all this information, the –OH group could be placed in the 
benzimidazole part, being an N-oxide the most plausible candidate. Otherwise, if the 
hydroxyl group was located in the alkylic chain, a second loss of water should in 
principle be observed in ESI+. 
Regarding the hydroxylated metabolite 2 (9.29 min, m/z 439.1645, C22H24N6O2Cl, -0.9 
ppm), two important fragment ions were observed at 10 eV (ESI+) at m/z 421.1538 
(C22H22N6OCl) and 403.1435 (C22H20N6Cl) corresponding to two consecutive losses of 
water. At higher collision energies, the common fragment ions at m/z 235.0983, 
207.0920, 192.0811, 190.0659 and 180.0808 were observed. The spectra in negative 
mode was different from that of losartan and the other hydroxylated metabolite (e.g. 
respectively m/z 187/157 or 203/173 were not seen) and only two product ions at m/z 
100.9908 (C3H2N2Cl) and 131.0008 (C4H4N2OCl) were observed. The presence of the –
OH group on the other N of the imidazole group would not explain the easy loss of 
water observed in ESI+. Another possibility would be the hydroxyl group to be located 
in the benzilic carbon, although this would hamper (but not prevent) the formation of 
the ions 235/207 in ESI+. 
After a literature search [29], three hydroxylated candidates were found (see the 
hydroxylated reported sites, marked as () in Figure 5): two metabolites are 
hydroxylated in the alkylic chain and the other in the benzilic carbon. However, on the 
basis of the MS/MS fragmentation, it was not possible to unequivocally locate the 
position of the –OH group. It would be very interesting to perform NMR to help 
identify the structure of these compounds. However, this was not possible due to the 
expected low concentrations of the discovered TPs together with the need for on-line 
coupling of UHPLC separations to NMR spectroscopy. Unfortunately, this type of 
instrumentation is not easy available in our area. 
It is interesting to remark that losartan, its carboxylic acid and the two hydroxylated 
metabolites were found in all water samples analysed (10 surface, 7 effluent WW, 7 
influent WW).  
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Conclusions 
The potential of UHPLC-QTOF MS for large screening of more than 1000 licit and illicit 
drugs, even without the need of having all reference standards available, has allowed the 
detection of many of these compounds in water samples from the area of Bogotá. The 
screening performed in urban wastewater and surface water confirmed the presence of 
emerging contaminants, mainly pharmaceuticals, in the samples. This work provides new 
information on the occurrence of these compounds and metabolites in the Colombian 
water cycle. The availability of full-spectrum acquisition accurate-mass QTOF data will 
also facilitate in the future, retrospective analysis of other contaminants not considered in 
this initial screening, if required. The results obtained in this first study may help 
Colombian institutions to select priority contaminants for future actions. Thus, target 
methodologies, typically based on LC-MS/MS, will need to be set up in the near future 
for accurate and sensitive quantification of the contaminants selected on the basis on the 
information provided in the present paper. 
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Supplementary information 
In this section, a table is shown of the human and veterinary pharmaceuticals including 
metabolites (Table SI1), X-Ray agents (Table SI2), UV-filters (Table SI3), 
preservatives (Table SI4), sweeteners (Table SI5) and illicit drugs including 
metabolites (Table SI6) studied.  
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Table 1. Positive findings by UHPLC-(Q)TOF MS in 10 surface water samples. Results obtained in influent and effluent samples. 
COMPOUND 
SURFACE WATER (number of the sampling site) INFLUENT* 
(n=7) 
EFFLUENT* 
(n=7) 1 2 3 4 5 6 7 8 9 10 
Pharmaceuticals and veterinary drugs 
4-Acetamido antipyine            
4-Formylamino antipyrine 

          
Acetaminophen/paracetamol    

 

   
Carbamazepine            
Carbamazepine 10,11-dihydro-
10,11-dihydroxy            
Clarithromycin            
Clindamycin            
Codeine            
Diclofenac            
Dimetridazole            
Gabapentin            
Gemfibrozil            
Ibuprofen            
Iopromide            
Irbesartan            
Ketoprofen            
Levamisole 

       


Lidocaine**              
Lincomycin 

        


Losartan            
Losartan, carboxylic acid**            
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Losartan, hydroxy (1)            
Losartan, hydroxy (2)            
Metformin 

          
Metoprolol           
Metronidazole            
Naproxen            
Pirantel            
Salbutamol  

        
Sulfamethoxazole            
Trimethoprim            
Valsartan            
Psychoactive drugs 
Benzoylecgonine            
Caffeine            
Cocaine             
Preservatives 
Methylparaben            
Propylparaben            
Sweeteners 
Acesulfame            
Saccharin            
Sucralose            
 () Detected, not confirmed (1 accurate-mass ion <5 ppm + retention time <2.5%). 
 () Confirmed with at least two accurate-mass ions (<5ppm) and retention time (<2.5%) with reference standard. 
 () Tentatively identified (at least two accurate-mass ions justified by literature data and/or compatible with the candidate chemical structure). 
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*Results given for IWW and EWW correspond to seven samples (one whole week). The compounds indicated as ,  or  were found in at least 6 out of 7 
samples analysed.  
**These compounds were firstly tentatively identified in the samples and afterwards confirmed with reference standards.  
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Figure captions  
 
Figure 1. Location of sampling sites 
Figure 2. Detection and identification of metabolite 4-acetylamino antipyrine in surface 
water by UHPLC-QTOF MS. (a) Low energy (LE, bottom) and high energy (HE, top) 
mass spectra for the peak at 3.78 min; (b) eXtracted Ion Chromatograms (XICs) at 150 
ppm mass window for [M+H]+ in LE, and main fragments in HE. 
Figure 3. Tentative identification of lidocaine and caffeine in effluent wastewater by 
UHPLC-QTOF MS. (a) LE and HE mass spectra for the peaks at 3.89 and 3.98 min in 
positive ionization mode; (b) XICs at 150 ppm mass window for [M+H]
+
 of lidocaine 
(3.98 min) and caffeine (3.89 min) in LE, and for the fragment ions (m/z 86, 138 and 
110) in HE. 
Figure 4. Common fragmentation pathway strategy applied for the detection of 
metabolites of losartan. (a) eXtracted Ion Chromatograms (XICs) at 150 ppm mass 
window for [M+H]
+
 of losartan in LE function, and (b) main fragments (m/z 207, 235, 
190) in HE function; (c) XICs at 150 ppm mass window for [M+H]
+
 of possible 
carboxylic acid metabolite in LE function; (d) XICs at 150 ppm mass window for 
[M+H]
+
 of possible hydroxylated metabolites of losartan in LE function. 
Figure 5. MS/MS spectra at 10 eV (bottom), 20 eV (middle) and 50 eV (top) for 
hydoxylated metabolite 1 (8.25 min) in (a) ESI+ and (b) ESI- 
() indicates the possible hydroxylation sites, as reported in the literature. 
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Sampling points 
Number Name/Description 
1 Landfill, Doña Juana (Tunjuelo river) 
2 San Benito (tanneries area) (Tunjuelo river) 
3 Guadalupe (slaughterhouse) (Tunjuelo river) 
4 Bosa (Tunjuelo river) 
5 Irrigation channel San Jose- La Victoria (Ramada irrigation area) 
6 Irrigation channel San Jose- Los Pinos (Ramada irrigation area) 
7 Wetland Güali-Tres Esquinas (Ramada irrigation area) 
8 Canal C. Agricultural Center, Marengo (Ramada irrigation area) 
9 Canal C. Agricultural Center, Marengo (Ramada irrigation area) 
10 Exit of swamp (Ramada irrigation area) 
11 Wastewater, Salitre WWTP 
Seven influent and seven effluent wastewater samples (one whole week) 
 
 
 
Figure 1. 
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Figure 2. 
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  Figure 3 
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    Figure 4  
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 Figure 5 
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